About the Authors

Claudio U. Köser

cuk21@cam.ac.uk

Affiliations Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom, Clinical Microbiology and Public Health Laboratory, Health Protection Agency Microbiology Services, Addenbrooke's Hospital, Cambridge, United Kingdom

Matthew J. Ellington

Affiliation Clinical Microbiology and Public Health Laboratory, Health Protection Agency Microbiology Services, Addenbrooke's Hospital, Cambridge, United Kingdom

Edward J. P. Cartwright

Affiliations Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom, Clinical Microbiology and Public Health Laboratory, Health Protection Agency Microbiology Services, Addenbrooke's Hospital, Cambridge, United Kingdom

Stephen H. Gillespie

Affiliation The Medical School University of St. Andrews, North Haugh, St. Andrews Fife, United Kingdom

Nicholas M. Brown

Affiliation Clinical Microbiology and Public Health Laboratory, Health Protection Agency Microbiology Services, Addenbrooke's Hospital, Cambridge, United Kingdom

Mark Farrington

Affiliation Clinical Microbiology and Public Health Laboratory, Health Protection Agency Microbiology Services, Addenbrooke's Hospital, Cambridge, United Kingdom

Matthew T. G. Holden

Affiliation The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

Gordon Dougan

Affiliation The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

Stephen D. Bentley

Affiliation The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

Julian Parkhill

Affiliation The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

Sharon J. Peacock

Affiliations Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom, Clinical Microbiology and Public Health Laboratory, Health Protection Agency Microbiology Services, Addenbrooke's Hospital, Cambridge, United Kingdom, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, Department of Pathology, University of Cambridge, Cambridge, United Kingdom

Competing Interests

I have read the journal's policy and have the following conflicts: CUK, MJE, EJPC, NMB, MTGH, GD, SDB, JP, and SJP have collaborated with Illumina Ltd. on a number of scientific projects. JP has received funding for travel and accommodation from Pacific Biosciences Inc. and Illumina Inc. NMB is a consultant for Astellas Pharma Ltd. SHG has received payments from Bayer Schering Health Care for lectures. SJP is a consultant for Pfizer Inc. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.